|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||2.70 / 14.00|
Provides Exclusive Access to Gene Editing and Pulmonary Endothelial Targeting Technologies
Wednesday, October 5th, 11 a.m. PDT/2:00 pm EDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits
Data Safety Monitoring Board Recommends Trial Continue
These five stocks trading for less than $10 a share are within range of triggering breakout trades.
Highlights Ongoing Initiatives Involving the AdenoVerse™ Gene Delivery Platform
Biotech stocks large and small were plummeting as 2016's painful start began to turn torturous.
Composition of Matter Protection for Proprietary Gorilla Vectors Expansion of AdenoVerse™ Platform Provides Multiple Opportunities for New Applications
Presentation Includes Emerging Data from Malaria Collaboration with NIAID
Wednesday, October 7th, 5:15 pm Pacific/8:15 pm EDT
Webcast Presentation Scheduled for Thursday, June 4th at 11 a.m. EDT
Webcast Presentation Scheduled for Monday, March 9th at 12 Noon PST
Webcast Presentation scheduled for Monday, February 9th at 1:00 p.m. EST
Sustained Immune Responses Protecting the Lung and Nose Against RSV Challenge Seen